Previous Article | Next Article ![]()
Infect Immun, January 1998, p. 247-258, Vol. 66, No. 1
James A. Baker Institute for Animal
Health,1
Department of
Pathology,2 and
Department of Clinical
Sciences,3 College of Veterinary Medicine,
Cornell University, Ithaca, New York 14853
Received 27 May 1997/Returned for modification 20 June
1997/Accepted 6 October 1997
Canine synovial membrane explants were exposed to high- or
low-passage Borrelia burgdorferi for 3, 6, 12, and 24 h. Spirochetes received no treatment, were UV light irradiated for
16 h, or were sonicated prior to addition to synovial explant
cultures. In explant tissues, mRNA levels for the proinflammatory
cytokines tumor necrosis factor alpha (TNF- Lyme disease or Lyme borreliosis is
a tick-borne disease of humans (41) and animals (1, 25,
33) caused by the spirochete Borrelia burgdorferi.
Disease-associated changes manifest themselves in one or several
organs, particularly the skin, joints, nervous system, and heart, and
the clinical outcome seems to depend on the genospecies of B. burgdorferi (50). The skin and musculoskeletal system
are the predominantly affected organ systems in North America, where
B. burgdorferi sensu stricto is the prevalent borrelia
species (41, 50).
Despite numerous studies, limited information is available on many
aspects of the pathogenesis of Lyme disease. For example, a detailed
description of the interplay between spirochete and host is lacking,
and so it is still unknown how spirochetes induce inflammation in
tissue. The accumulation of leukocytes in the joint capsules and joint
cavity during the acute phase of Lyme arthritis has been studied in
humans, mice, and dogs (4, 41, 45). In dogs this leukocyte
population is up to 97% polymorphonuclear neutrophils (PMNs),
indicating an important role for PMNs during the early stage of acute
Lyme arthritis. PMNs egress from blood vessels, and migration and
accumulation in tissue require the up-regulation of endothelial
adhesion factors and a source of chemotactic factors. Tumor necrosis
factor alpha (TNF- During B. burgdorferi infection in humans and dogs,
spirochetes were found in inflamed tissues and frequently in arthritic joints (7, 12, 42). Additionally, B. burgdorferi
was shown to be a potent cytokine-stimulating factor in vitro. Cells
tested in different systems consisted of blood monocytes, macrophages, lymphocytes, and fibroblasts, and the production of TNF- In studies of infectious diseases, most in vitro systems employ single
cell populations to evaluate the response to specific stimuli.
Obviously, interactions between different cell types cannot occur in
these systems, and positive and negative feedback mechanisms may not
develop. Explant cultures, on the other hand, contain a variety of
different cell types, which allow the study of a complex and more
natural response of a tissue to extrinsic factors. Recently, we have
demonstrated in vivo that IL-8 is produced and released in synovial
membranes during acute experimental Lyme arthritis in dogs
(45). The in vivo study did not entirely rule out the
possibility of immune complex involvement in the pathogenesis of this
disease. One product generated by immune complexes is the complement
factor C5a, which, like IL-8, is also a potent chemotactic factor for
PMNs.
In this study we investigated the effect of B. burgdorferi
on canine synovial explant cultures in the absence of borrelia-specific antibodies and complement factors. This model provides an opportunity to investigate the synovial cytokine response at the level of mRNA
expression and cytokine release following B. burgdorferi challenge under controlled conditions. As Lyme arthritis in dogs shares
clinical and pathological features with the disease in human beings
(1), these studies should be of considerable comparative interest.
B. burgdorferi.
High-passage (passage 45 [P45] and
P46) and low-passage (P2 and P3) B. burgdorferi organisms,
originally isolated from skin biopsies of experimentally infected dogs,
were used for these experiments. The dogs had been exposed to infected
ticks collected in North Salem, Westchester County, N.Y.
(1). Cultures were propagated and passaged in BSK II medium
with 8 µg of kanamycin (Sigma, St. Louis, Mo.) per ml and 50 µg of
rifampin (Sigma) per ml at 34°C. One-milliliter aliquots of
spirochete suspensions (P43 or original reisolate) containing 15%
glycerin (Sigma) were frozen at
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Borrelia burgdorferi Induces the
Production and Release of Proinflammatory Cytokines in Canine Synovial
Explant Cultures
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
), interleukin-1
(IL-1
), IL-1
, and IL-8 were surveyed semiquantitatively by
reverse transcription-PCR. Culture supernatants were examined for
numbers of total and motile (i.e., viable) spirochetes, TNF-like and
IL-1-like activities, polymorphonuclear neutrophil (PMN)
chemotaxis-inducing activities, and IL-8. During exposure to synovial
explant tissues, the total number of spirochetes in the supernatants
decreased gradually by ~30%, and the viability also declined. mRNAs
for TNF-
, IL-1
, IL-1
, and IL-8 were up-regulated in synovial
explant tissues within 3 h after infection with untreated or UV
light-irradiated B. burgdorferi, and mRNA levels
corresponded to the results obtained with bioassays. During 24 h
of coincubation, cultures challenged with untreated or UV
light-irradiated spirochetes produced similar levels of TNF-like and
IL-1-like activities. In contrast, explant tissues exposed to untreated
B. burgdorferi generated significantly higher levels of
chemotactic factors after 24 h of incubation than did explant
tissues exposed to UV light-treated spirochetes. In identical samples,
a specific signal for IL-8 was identified by Western blot analysis.
High- and low-passage borreliae did not differ in their abilities to
induce proinflammatory cytokines. No difference in cytokine induction
between untreated and sonicated high-passage spirochetes was observed,
suggesting that fractions of the organism can trigger the production
and release of inflammatory mediators. The titration of spirochetes
revealed a dose-independent cytokine response, where 103 to
107 B. burgdorferi organisms induced similar
TNF-like activities but only 107 spirochetes induced
measurable IL-1-like activities. The release of chemotactic factors was
dose dependent and was initiated when tissues were infected with at
least 105 organisms. We conclude that intact B. burgdorferi or fractions of the bacterium can induce the local
up-regulation of TNF-
, IL-1
, and IL-1
in the synovium but that
the interaction of viable spirochetes with synovial cells leads to the
release of IL-8, which probably is a prime initiator of PMN migration
during acute Lyme arthritis.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
), gamma interferon, interleukin-1
(IL-1
),
IL-1
, IL-1 receptor antagonist, IL-6, and leukotriene B4
are factors that have been reported to be involved in Lyme arthritis
(5, 8, 13, 26, 27, 53). In contrast, surprisingly little
information is available on the involvement of IL-8, which is a potent
initiator of migration of PMNs and other leukocytes from blood vessels
into tissue (2).
, gamma interferon, IL-1
, IL-1
, IL-2, IL-4, IL-6, and IL-8 was studied (8, 16-18, 24, 34, 36, 40). In some studies, live organisms exhibited stronger stimulatory effects than heat-inactivated
spirochetes (17, 18), pointing to an active interaction
between viable spirochetes and host cells. However, outer surface
proteins of B. burgdorferi, such as OspA and OspB, possess
mitogenic and cytokine-stimulating properties (19, 24, 46).
IL-1
was reported to be induced by the activation of the nuclear
translocation factor NF-
B (32).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
80°C. For explant experiments,
aliquots were thawed and inoculated into 6 ml of BSK II medium with
kanamycin and rifampin. Cultures were incubated at 34°C. During the
following two passages, spirochetes were cultured at 34°C for 2 days
(P45 and P46) or 3 days (P2 and P3) before they were added to explant
cultures. Spirochetes were sedimented at 10,000 × g
for 20 min at 4°C, and the pellet was resuspended in serum-free
Hanks' balanced salt solution (HBSS) without phenol red (Sigma) and
with 8 µg of kanamycin per ml (HBSS + K). Bacterial cell counts
and viability of the spirochetes were determined with a Petroff-Hausser
counting chamber (Krackeler, Albany, N.Y.), and the concentration of
the bacteria was adjusted to 1.4 × 108 to 2.6 × 108 borreliae/ml. This concentration was estimated to yield
a cell/bacterium ratio of at least 1:10. Motile spirochetes were
considered viable. In four experiments, 50% of the cultures were
transferred into 10-cm-diameter petri dishes and irradiated with UV
light at a distance of 30 cm for 16 h to obtain bacterial
suspensions with whole nonmotile organisms. In a fifth experiment, 50%
of the spirochete suspension was subjected to sonication. In a final
experiment, the number of spirochetes added to synovial explant tissues
was varied (107, 105, 103 per
tissue) (Table 1).
TABLE 1.
B. burgdorferi and canine tissues used in
synovial explant cultures
Synovial explant cultures. Synovial membranes were collected from the knee joints of six normal Labrador retrievers from the James A. Baker Institute colony. The dogs were 8 to 14 months old and were kept in conformance with the Animal Welfare Act and the New York State Department of Health regulations.
All synovial explant cultures were maintained in 24-well plates (Corning, Corning, N.Y.) in HBSS + K. After euthanasia of the dogs, synovial membranes from the knees were removed under sterile conditions and immersed in HBSS + K. Membranes were cut into pieces (approximately 5 by 5 mm) and transferred into 24-well plates, which contained 0.9 ml of HBSS + K without serum in each well. In 13 preliminary experiments, different media (BSK II, RPMI 1640, and HBSS, all with and without phenol red or with and without fetal bovine serum [FBS]) were evaluated for spirochete and tissue survival in vitro. In addition, conditions for reliable cytokine detection in tissues and culture supernatants were established. As a consequence, BSK II-free HBSS was chosen for its ability to support short-term survival of borreliae in culture. FBS was eliminated because it could have contained factors (chemokines or complement) which would have interfered with the chemotaxis assay and with Western blots. Plates were incubated at 37°C in humidified air with 5% CO2 for 30 min before the addition of the spirochetes. Cocultivation of synovial explant tissues with B. burgdorferi was performed in quadruplicate. Explant cultures received 100 µl of either medium only, medium with borreliae, or medium with irradiated or sonicated borreliae. As further controls, plates without synovial membranes were prepared with identical contents. Cultures were held at 37°C in humidified air with 5% CO2. After 3, 6, 12, and 24 h of cocultivation, tissues and culture supernatants were harvested. At these time intervals, the number and viability of the spirochetes in the culture medium were determined with a counting chamber. Tissues were removed from the culture plates, transferred into siliconized 1.5-ml microcentrifuge tubes (Laboratory Product Sales, Rochester, N.Y.), snap frozen in liquid nitrogen, and stored at
80°C until used. Supernatants were transferred into
1.5-ml microcentrifuge tubes and centrifuged at 2,000 × g for 10 min in a microcentrifuge (Eppendorf, Hamburg,
Germany). Aliquots of the cell-free supernatants were stored at
80°C until used.
Detection of mRNAs of TNF-
, IL-1
, IL-1
, and IL-8 by
RT-PCR.
Extraction of RNA, transcription into cDNA and subsequent
DNA amplification, and separation and visualization of DNA were done in
different rooms with different sets of instruments to avoid any
contamination with previously amplified DNA fragments.
(i) Extraction of total RNA.
Total RNA was extracted from
explant culture tissues with an RNA extraction kit from Qiagen
(Chatsworth, Calif.). Glassware and metal grinders were held at 280°C
for 8 h prior to any experiment. RNase-free plastic supplies were
kept under contamination-free conditions. Experiments were performed in
siliconized plastic tubes. Tissues were homogenized in 1.5-ml Eppendorf
tubes with the supplied lysis buffer, and tissue particles were removed
by centrifugation (18,000 × g, 3 min). mRNA-containing
supernatant was removed, mixed with the same volume of 70% ethanol,
and applied to RNA-absorbent spin columns. Washing steps were carried
out according to the manufacturer's protocol to remove protein and DNA, and remaining mRNA was recovered with diethyl pyrocarbonate (Sigma)-treated water. The amount and the purity of extracted total RNA
were measured with a spectrophotometer (
1 = 260 nm and
2 = 280 nm) (Beckman, Fullerton, Calif.).
(ii) RT.
Reactions were carried out in a GeneAmp 9600 PCR
system (Perkin-Elmer). One-tenth microgram of total RNA in 50 µl of
reverse transcription (RT) buffer containing 1× PCR Buffer II
(Perkin-Elmer), 5.0 mM MgCl2 (Perkin-Elmer), 1.0 mM each
deoxynucleoside triphosphate (Perkin-Elmer), 18 U of RNase inhibitor
(Promega, Madison, Wis.), 200 U of Moloney murine leukemia virus
reverse transcriptase (Amersham, Arlington Heights, Ill.), and 2.5 mM
oligo(dT)18 (New England Biolabs, Beverly, Mass.) was
transcribed into cDNA at 24°C for 10 min followed by 42°C for 30 min. The cDNA then was held at 98°C for 5 min. Five-microliter
aliquots of each sample were transferred into new 96-well microtiter
plates, sealed with adhesive sealer tape, and stored at
80°C until
used.
(iii) PCR.
PCR primers for canine TNF-
, IL-1
, and IL-8
were designed based on the published sequences for canine TNF-
(55), canine IL-1
(11), and canine IL-8
(14). The primer set for canine IL-1
was designed to bind
to highly conserved regions of IL-1
mRNA from human (30),
rhesus monkey (51), guinea pig (54), rat
(31), and cattle (20). The sequences of the
primers (F, forward; R, reverse) are as follows: TNF-
-F,
5'-CTCTTCTGCCTGCTGCAC-3'; TNF-
-R,
5'-GCCCTTGAAGAGGACCTG-3'; IL-1
-F,
5'-TTTGAAGACCTGAAGAACTGTTAC-3'; IL-1
-R,
5'-GTTTTTGAGATTCTTAGA(G/A)TCAC-3'; IL-1
-F,
5'-CACAGTTCTCTGGTAGATGAGG-3'; IL-1
-R,
5'-TGGCTTATGTCCTGTAACTTGC-3'; IL-8-F,
5'-AGGGATCCTGTGTAAACATGACTTCC-3'; and IL-8-R,
5'-GGAATTCACGGATCTTGTTTCTC-3'. These primers were predicted
to amplify a 288-bp fragment for TNF-
, a 545-bp fragment for
IL-1
, a 262-bp fragment for IL-1
, and a 330-bp fragment for IL-8
with cDNA as a template. Primers originally designed to amplify a
fragment from the published bovine
-actin sequence (BAC-1,
5'-ATGTTCAGGGACTTTGGACG-3'; BAC-2,
5'-ACCAGCCATCCAGACAAAAC-3' [47]) were found
to amplify a homologous segment of the canine
-actin. They were used
to monitor the amount of mRNA in the reaction. PCR was performed with a
GeneAmp 9600 PCR system (Perkin-Elmer) in a 25-µl total reaction
volume, which was prepared with 5 µl of the cDNA solution, 1× PCR
Buffer II (Perkin-Elmer), 1.0 µM each primer, and 0.6 U of
Taq polymerase (Perkin-Elmer). The MgCl2 concentration was adjusted to 1.5 mM. The DNA amplification reactions included 94°C for 2 min, followed by amplification cycles of 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min for TNF-
, IL-1
, and IL-8, and
-actin. The annealing temperature for IL-1
was adjusted to 60°C. The reactions ended with an extension at 72°C for
6 min. TNF-
mRNA was amplified during 33 cycles, IL-1
mRNA was
amplified during 26 cycles, IL-1
mRNA was amplified during 21 cycles, IL-8 mRNA was amplified during 18 cycles, and
-actin mRNA
was amplified during 30 cycles. PCR fragments were separated in 1.5%
agarose gels and visualized with ethidium bromide (37).
(iv) Sequence analysis.
Visualized DNA fragments were cut
out from agarose gels and served as templates for a subsequent PCR
amplification. Reamplified DNA fragments were purified and concentrated
with the QIAquick PCR purification kit (Qiagen) according to the
manufacturer's protocol. Automated sequencing was performed (Applied
Biosystems 373 DNA sequencer; Cornell Biotechnology), and readouts were
compared to published canine sequences or, in the case of IL-1
, to
published sequences from other species by using Lasergene Software
(DNAStar, Madison, Wis.).
Bioassays for canine TNF and IL-1. Canine cytokine activities were measured by cytotoxicity assays with cytokine-sensitive cell lines as described by Yamashita et al. (52) and Judd and MacLeod (15).
(i) TNF.
TNF-sensitive murine sarcoma cells (WEHI 164.S13)
were purchased from the American Type Culture Collection (Rockville,
Md.) (ATCC CRL 1751). Cells were propagated in RPMI 1640 with 25 mM HEPES and L-glutamine (Gibco BRL, Grand Island, N.Y.), 50 µg of gentamicin (Gibco BRL) per ml, and 10% FBS (Gibco BRL). Cells were incubated at 37°C with 5% CO2 for 72 h, and
then they were scraped off for further propagation or tests. TNF was
assayed in 96-well flat-bottomed plates, and all samples (diluted 1:10 in medium without phenol red) were tested in triplicate. A threefold dilution series of recombinant human TNF-
(rhTNF-
) (R&D Systems, Minneapolis, Minn.), ranging in final concentration from 0.1 pg/ml to
25 ng/ml, served as a positive control. To achieve comparable conditions in the test samples and positive control, rhTNF-
was diluted in medium containing 80% RPMI 1640 without phenol red and 20%
HBSS. Each test well contained 200 µl of medium (RPMI 1640 without
phenol red and with 5% FBS), rhTNF-
or 1:10 diluted sample, and
10,000 cells. After 24 h, TNF activity was assessed by measuring
cell viability with XTT
(2,3-bis-[2-methoxy-4-nitro-5-sulfo-phenyl]-2H-tetrazolium-5-carboxanilide inner salt) as described by Stevens and Olsen (43). Eighteen hours after the addition of XTT, the optical density of the culture supernatant was measured with a reader at
1 = 490 nm and
2 = 630 nm. TNF activities were calculated and expressed
as rhTNF-
-like activities.
, samples with
confirmed rhTNF-
-like activities were incubated with the same volume
of phosphate-buffered saline (PBS) containing a 10-µg/ml
concentration of polyclonal antibodies raised against rhTNF-
(R&D
Systems). Samples were incubated for 2 h on a shaker (200 rpm).
Identical samples were incubated with the same volume of PBS.
Subsequently, these samples were tested in the TNF bioassay.
(ii) IL-1.
An IL-1-sensitive human melanoma cell line,
A275.S2, was purchased from the American Type Culture Collection (ATCC
CRL 1619). Cells were cultured in minimal essential medium with 50 µg
of gentamicin (Gibco BRL) per ml and with 8% FBS. Confluent cell monolayers were obtained after 72 h when flasks were incubated at
37°C in humidified air with 5% CO2. For propagation and
testing, cells were detached from the flask with trypsin (0.05%) and
EDTA (0.025%) in a 0.9% sodium chloride solution. IL-1 testing was done in 96-well flat-bottomed plates as described for TNF testing. rhIL-1
(R&D Systems) was used as a positive control. The
biologically active concentration ranged between 0.01 pg/ml and 2.5 ng/ml. Samples and positive controls were tested in minimal essential medium with gentamicin and with 5% FBS. Plates were incubated for
72 h before the medium was taken off, plates were washed twice with RPMI 1640 without phenol red, wells were filled with 200 µl of
RPMI 1640 without phenol red and with 5% FBS, and XTT was added.
Results were calculated as rhIL-1
-like activity.
, samples with
confirmed rhIL-1
-like activities were incubated with the same volume
of PBS containing a 10-µg/ml concentration of polyclonal antibodies
raised against rhIL-1
(R&D Systems). Samples were incubated for
2 h on a shaker (200 rpm). Identical samples were incubated with
the same volume of PBS. Subsequently, these samples were tested in the
IL-1-bioassay.
Chemotactic activity of explant culture supernatants. (i) Chemotaxis assay. PMNs were isolated from heparinized venous blood from healthy specific-pathogen-free beagles (James A. Baker Institute). Cells were isolated by Hypaque-Ficoll density gradient centrifugation as described previously (45). Migration of PMNs through polycarbonate filters (2-µm pore diameter) was measured in a 96-blind-well chamber system (Neuro Probe, Cabin John, Md.). Two chemotaxis systems were used: in initial studies we employed a regular 96-well chemotaxis system (100 µl of diluted test sample), but more recently we used the ChemoTX system (30 µl of diluted test sample). The two systems gave similar results. Samples were diluted 1:10 in HBSS and tested in duplicate. Recombinant canine IL-8 (rcIL-8) was used as a positive control. The number of migrated PMNs was determined indirectly by measuring the amount of liberated peroxidase colorimetrically as described elsewhere (45).
(ii) Effect of polyclonal antibodies to rcIL-8 on chemotaxis. Explant supernatants with known chemotactic activity were incubated for 2 h at 37°C on a shaker at 200 rpm with polyclonal rabbit antiserum raised against rcIL-8 (45). Preimmune serum from the same rabbit served as a negative control. Previous experiments with rcIL-8 revealed an optimal blocking concentration of the serum at a dilution factor of 1:400. After the incubation period, samples were transferred into the wells of the chemotaxis unit, and the migration of PMNs was determined.
(iii) Checkerboard analysis. In further experiments conducted to differentiate between directed chemotaxis and random chemokinesis of PMNs, both the lower wells and the upper compartments were filled with various concentrations of PMN migration-inducing supernatants. Wells in the lower compartment were filled with solutions containing 10, 4, 1.6, and 0% of a PMN migration-inducing supernatant. Similarly, wells in the upper compartment were filled with PMN suspensions also containing 10, 4, 1.6, and 0% of the same supernatant, but the setup of the upper plate was then rotated 90° relative to the lower plate to achieve the checkerboard effect. In total, migration responses to 16 different combinations were evaluated.
SDS-PAGE and Western blotting for canine IL-8. Cell-free synovial explant culture supernatants were concentrated fivefold by lyophilization, and proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 15% polyacrylamide gels in an SE 600 gel apparatus (Hoefer Scientific Instruments, San Francisco, Calif.). Proteins were then transferred onto nylon membranes (Immobilon-P; Millipore, Bedford, Mass.) with a Hoefer TE 52× Transphor Unit at 25 V for 16 h. Membranes were blocked with bovine serum albumin (BSA) (3% in PBS) for 2 h at room temperature. After the incubation with a rabbit antiserum raised against rcIL-8 (diluted to 1:2,000 in PBS supplemented with 0.1% BSA) for 2 h at room temperature, membranes were exposed to biotin-labeled goat anti-rabbit antibodies (Cappel, Durham, N.C.) for 1 h at room temperature. Following the incubation with peroxidase-labeled avidin (Cappel) (1:2,000 in PBS-BSA) for 1 h at room temperature, the reaction was visualized by the use of the peroxidase substrate 3,3'-diaminobenzidine (Sigma). The molecular weights of the protein bands were estimated by use of prestained low-molecular-weight markers (Sigma) on the same gel. For direct identification of immunoreactive bands, a standard of purified rcIL-8 was also included on blots.
Histology. At the time of harvest after 3, 6, 12, or 24 h of cocultivation, uninfected synovial tissues and tissues infected with untreated or UV light-treated B. burgdorferi were fixed in 10% buffered formalin, trimmed, embedded, cut, and stained with hematoxylin and eosin (H&E) according to standard procedures.
Statistics.
Data from experiments 1 and 2 (explant tissues
infected with high-passage untreated or UV light-irradiated B. burgdorferi) or from experiments 3 and 4 (explant tissues infected
with low-passage untreated or UV light-irradiated B. burgdorferi) were combined. To eliminate outliers, Dixon's
criterion with a 5% error level was applied. Means and pooled standard
deviations (SD) (SD = [(SS1 + SS2)/(n1
n2
2)]1/2, where SS is sums of
squares, n is the number of samples, and the index is the
experiment number [38]) were calculated for each
value. Standard errors (SE) were derived from SD. Single values were
considered significantly different when they differed based on their
approximate 95% confidence intervals (based on 2 × SE). Effects
of neutralizing antibodies were investigated with paired samples.
Differences were calculated and tested in one-sample t tests
with a 95% confidence interval.
| |
RESULTS |
|---|
|
|
|---|
Synovial explant cultures. Synovial explant tissues from healthy dogs were cocultured with untreated, UV light-inactivated, or sonicated B. burgdorferi in HBSS for 3, 6, 12, and 24 h. A total of 1.4 × 107 to 2.6 × 107 spirochetes were added to each culture well containing medium with or without synovial explant tissues. Bacterial counts and viability were monitored in four experiments, where untreated and UV light-inactivated high-passage and low-passage borreliae were used. During the following 24-h observation period, the total number of spirochetes (sum of motile and nonmotile spirochetes) in the supernatants decreased gradually to 1.0 × 107 to 1.3 × 107 borreliae per well, a reduction of 24 to 34% (Fig. 1). During the same time period, the proportion of viable organisms decreased from initially 88% to 16 to 29% in cultures containing untreated spirochetes and from initially 13 to 0% in cultures containing UV light-inactivated spirochetes (Fig. 1).
|
Detection of mRNAs of TNF-
, IL-1
, IL-1
, and IL-8 by
RT-PCR.
mRNAs for canine proinflammatory cytokines were detected
by a semiquantitative RT-PCR. Equal amounts of total RNA were
transcribed into cDNA, the resulting cDNA was amplified by PCR, and
amplified fragments were visualized by gel electrophoresis. Sequence
analysis showed that signals for
-actin, TNF-
, IL-1
, and IL-8
were identical to published sequences. An IL-1
fragment, which was
amplified with primers annealing to consensus sequences derived from
different species and which was shorter than the expected fragment,
showed 81.9% homology to bovine IL-1
. Canine
-actin served as an
internal control to monitor the amount of RNA present in each
experiment and was detected in similar amounts in all samples tested.
Figure 2 shows a typical cytokine pattern
for one experiment (experiment 2) with high-passage untreated and
high-passage UV light-treated B. burgdorferi. When
experiments were initiated (t = 0 h), no mRNA for
any cytokine was detected. After 3 h of cultivation, a slight
up-regulation of mRNAs of all cytokines was detected in uninfected
explant tissues, which was observed throughout the 24-h cultivation
period. Explant tissues infected with untreated, motile borreliae
responded by 3 h with a pronounced up-regulation of TNF-
,
IL-1
, and IL-1
. Tissues challenged with UV light-irradiated B. burgdorferi mounted a weaker response at 3 h. After
6, 12, and 24 h of incubation, bands with similar intensities were
observed in samples from both systems. IL-8 mRNA up-regulation
increased over time in tissues exposed to untreated borreliae, reaching its maximum after 6 h and staying elevated thereafter. Again, explant tissues cocultivated with UV light-treated B. burgdorferi responded slower, reaching maximal IL-8 mRNA levels
after 12 h of cocultivation. No difference between high-passage
and low-passage borreliae was noticed (data not shown).
|
and IL-1
mRNAs were detected after 6 h of cocultivation, whereas IL-1
mRNA increased steadily during the
first 12 h to reach maximum levels at 12 and 24 h. IL-8 mRNA was detectable at low levels in 6-h samples. Afterwards, the level of
up-regulation increased, and it was maximal at 24 h of
cocultivation with sonicated spirochetes.
Bioassays for TNF and IL-1.
TNF and IL-1 activities in culture
supernatants were measured with a cytotoxicity assay using
cytokine-sensitive WEHI 164.S13 and A275.S2 cells, respectively.
Activities were expressed as rhTNF-
-like and rhIL-1
-like
activities, since rhTNF-
and rhIL-1
were used as the positive
controls and specific neutralizing antibodies against canine TNF and
IL-1 were not available.
(i) TNF.
In experiments 1 and 2, synovial explant tissues were
infected with high-passage untreated or UV light-treated B. burgdorferi (Fig. 3). Synovial
explant tissues alone released no substances with TNF activities during
the first 12 h of cultivation, while at 24 h, minimal
rhTNF-
-like activities were detected. In contrast, synovial explant
tissues exposed to untreated or UV light-treated B. burgdorferi released increasing amounts of rhTNF-
-like factors into supernatants over a 12-h incubation period. TNF activities dropped
after 24 h but did not differ statistically from the 12-h data.
Medium alone or with spirochetes had no effect on TNF-sensitive cells
(P > 0.05). No difference between the effects induced
by high-passage and low-passage B. burgdorferi was noticed
(data not shown).
|
-like
activity values were in general lower, but the same pattern of TNF
activity over time as in previous experiments was seen. Supernatants
from cultures with explant tissues and untreated spirochetes contained the following TNF activities: 0.15 ± 0.15 ng/ml at 3 h,
0.57 ± 0.21 ng/ml at 6 h, 1.02 ± 0.09 ng/ml at 12 h, and 0.85 ± 0.36 ng/ml at 24 h. Supernatants with
sonicated organisms showed the following activities: 0.30 ± 0.20 ng/ml at 3 h, 0.26 ± 0.10 ng/ml at 6 h, 0.46 ± 0.20 ng/ml at 12 h, and 0.43 ± 0.25 ng/ml at 24 h.
TNF activities in 6-, 12-, and 24-h supernatants from explant cultures
receiving 103, 105, or 107
spirochetes did not differ significantly (Fig.
4) (P > 0.05). TNF
activity was up-regulated as in previous experiments and reached maximum values after 12 and 24 h of cocultivation (between
1.98 ± 0.27 and 2.51 ± 0.98 ng of rhTNF-
-like activity
per ml). Only after 3 h was a dose-dependent rhTNF-
-like
response noticed (0.19 ± 0.06 ng/ml with 107
borreliae, 0.11 ± 0.06 ng/ml with 105 borreliae, and
0.07 ± 0.02 ng/ml with 103 borreliae per explant).
|
were used to demonstrate the
specificity of the putative TNF-like activities in explant supernatants. A 5-µg/ml antibody solution reduced the effect of rhTNF-
by 100% when rhTNF-
was used at a concentration of below 0.01 ng/ml. When rhTNF-
was used at concentrations of between 0.01 and 1.0 ng/ml, the efficacy in inhibiting TNF-
-like activity with
antibodies dropped gradually to 10%. The same antibody solution reduced the TNF-like activity in 1:10-diluted explant supernatants on
average by 32% (P < 0.0001; maximal inhibition,
85%).
(ii) IL-1.
Aliquots of the same supernatants that were tested
for TNF activity were screened for IL-1 activity. The combined results of two experiments (experiments 1 and 2) with high-passage untreated and high-passage UV light-treated B. burgdorferi are shown
in Fig. 5. The IL-1 assay did not
distinguish between IL-1
and IL-1
. After 3 h of cultivation,
no rhIL-1
-like activity was detected in any synovial explant
tissues. At 6 h, supernatants from synovial explant tissues
exposed to untreated or irradiated spirochetes showed little
rhIL-1
-like activity when uninfected tissues did not. During the
following 18 h of co-cultivation, the rhIL-1
-like activity
increased significantly over background values in cultures with explant
tissues exposed to untreated borreliae and to a lesser concentration in
cultures with explant tissues exposed to UV light-treated borreliae. At
24 h, supernatants of explant tissues alone produced an
rhIL-1
-like activity of 0.80 ± 0.76 ng/ml, which because of a
high SD did not differ significantly from that of cultures with explant
tissue exposed to UV light-treated borreliae (P > 0.05). Medium alone or with spirochetes did not exhibit any
rhIL-1
-like activity. Supernatants of explant cultures with
high-passage and low-passage borreliae did not differ in their patterns
and magnitudes of rhIL-1
-like activity (data not shown).
|
-like activity was detected in 12-h samples (0.47 ± 0.20 ng/ml) and in
24-h samples (4.51 ± 1.36 ng/ml). In the same experiment,
untreated borreliae induced rhIL-1
-like activity of 0.81 ± 0.06 and 3.81 ± 0.94 ng/ml after 12 and 24 h of
cocultivation with synovial explant tissues, respectively.
Synovial explant tissues were very unresponsive in terms of IL-1
release to low numbers of spirochetes added to the culture medium. In
the titration experiment, only an inoculum of 107 untreated
spirochetes per tissue induced the release of IL-1-like substances
(0.54 ± 0.13 ng/ml at 12 h and 1.97 ± 0.37 ng/ml at 24 h). No rhIL-1
-like activity was detected in cultures with 105 and 103 B. burgdorferi organisms
per synovial explant tissue (Fig. 4).
Since neutralizing antibodies against canine IL-1
and IL-1
were
not available, explant culture supernatants were incubated with
polyclonal antibodies against rhIL-1
. A 5-µg/ml antibody solution
reduced the effect of rhIL-1
by more than 95% when rhIL-1
was
used at a concentration of below 0.5 ng/ml. When supernatants from
explant cultures were tested, IL-1-like activity was minimally reduced, and only a few samples (1:10 dilutions) showed reductions of
up to 35% (P = 0.25).
Chemotactic activity of explant culture supernatants. Synovial explant culture supernatants were tested for their ability to induce the migration of PMNs from normal beagles through polycarbonate filters in vitro. No difference in migration behavior was seen when a regular 96-well chemotaxis system with a large sample volume was used or when the Chemo TX system, which needs only a third of the sample volume, was used. Combined results from experiments 1 and 2 with high-passage untreated and high-passage UV light-treated B. burgdorferi are shown in Fig. 6. No chemotactic activity was detected in supernatants from 3-h cultures. After 6 h of cultivation, only cultures with untreated spirochetes showed slight chemotaxis which differed significantly from background levels (P < 0.05). Chemotactic activity increased gradually in supernatants of synovial explant tissues with untreated and UV light-treated borreliae during the following 18 h of cultivation. After 24 h, maximal concentrations were reached in cultures with untreated and UV light-treated B. burgdorferi, which differed significantly (P < 0.05). Similar results were obtained from explant experiments utilizing low-passage B. burgdorferi (data not shown).
|
|
SDS-PAGE and Western blotting for canine IL-8. Concentrated supernatants from two synovial explant experiments (high and low passage) were subjected to SDS-PAGE analysis, and membrane-bound proteins were incubated with polyclonal antibodies raised against rcIL-8. One blot (from experiment 1 with high-passage borreliae) is shown in Fig. 7. After 3 and 6 h of cocultivation, no detectable concentrations of canine IL-8 were present in any samples. After an additional 6 h, samples of synovial explant tissues with untreated borreliae showed a band in the range of 8 kDa, which was identical in size to rcIL-8. A less prominent band was visible in the lane which contained the sample of explant tissue in combination with UV light-treated borreliae. The 24-h samples revealed stronger bands for IL-8 in both samples where synovial explant tissues were challenged with untreated or UV light-treated B. burgdorferi. Additional bands were visible between 10 and 15 kDa, which appeared in all test samples containing synovial explant tissues regardless of the spirochete challenge. Since hyperimmune serum was used, these bands can be interpreted as nonspecific signals of unknown origin.
|
Histology. Formalin-fixed, paraffin-embedded, and H&E-stained tissues were examined by light microscopy (Fig. 8). During a 24-h period of incubation in HBSS, explant tissues retained remarkable integrity and expressed only minor signs of deterioration. Explant surfaces were covered with one or two layers of synoviocytes. The stroma of the explant tissues contained collagenous connective tissue with fibrocytes, blood vessels, and islands of adipose tissue. The blood vessels were mostly capillaries, with infrequent small arterioles. Surprisingly, some vessels contained intact erythrocytes. Below the synoviocyte layer, a few degenerating cells with pyknotic nuclei were found in all examined tissues. No histological differences between control tissues and tissues cocultured with B. burgdorferi were noted. Spirochetes are not visible in H&E-stained tissues.
|
| |
DISCUSSION |
|---|
|
|
|---|
The clinical onset of Lyme arthritis in humans and dogs is
typically abrupt. When histological and cytological examinations of
synovial membranes and synovial fluids from affected joints are made, a
massive influx of PMNs into the joint cavity is evident (1,
10). PMNs and other cells do not invade tissues randomly but do
so in response to distinct signals which ultimately will induce their
migration from blood vessels through tissue and into the joint cavity.
Our in vivo studies with dogs (45) have shown that B. burgdorferi is present in inflamed joints and that IL-8, a strong
chemoattractant for PMNs, is involved in the pathogenesis of the
disease. This prompted us to investigate the interaction of B. burgdorferi with synovial membranes in vitro. We have chosen to
use canine synovial explant tissue cultures rather than isolated cell
populations or specific cell lines, which represent only single cell
populations and, further, would not allow any feedback mechanisms
between different cell types. In addition, explant cultures provide a
natural three-dimensional structure, which remained histologically
intact throughout the 24-h incubation period. This system allowed
cell-to-cell communication but excluded the effects of blood-borne
factors such as antibodies, complement, and leukocytes. The kinetics of
proinflammatory cytokines, e.g., TNF-
, IL-1
, IL-1
, and IL-8,
were investigated, because the predominance of PMNs in inflamed tissues
during acute phases of the natural occurring disease points to the
involvement of those factors.
In five experiments, each synovial explant tissue culture was infected
with 107 or more spirochetes. This number of spirochetes
exceeds by far the number of spirochetes naturally found in infected
tissues. B. burgdorferi is difficult to demonstrate by
either culture or PCR in clinical specimens (3, 35),
suggesting that the number of organisms is low in vivo. We intended to
simulate extreme conditions in vitro, and our titration experiment
demonstrated that a high number of spirochetes resulted in the maximal
production and release of all the cytokines that we investigated. Under
the assumption that a 5- by 5-mm synovial explant membrane contains
106 to 107 cells (a cell volume of
103 to 104 µm3 is assumed), a
cell/spirochete ratio of more than 1.0 was achieved. This is in
accordance with results from Defosse and Johnson (8), Kenefick et al. (18), and Burns et al. (6), who
demonstrated that a cell/spirochete ratio of 1:1 or greater induced a
TNF-
or IL-1 response in mononuclear cells or umbilical endothelial cells in vitro.
Since B. burgdorferi moves actively in culture media and apparently migrates in tissues as well (45), we investigated the effects of motile borreliae compared to those of UV light-irradiated or sonicated borreliae on synovial explant tissues. During the 24-h incubation period, the number of spirochetes in culture supernatants dropped by a maximum of 34%, which may be the result of sedimentation, because controls without explant tissues showed a similar reduction in number. During the same time, the viability of the organisms declined also. This is not surprising, since HBSS is not a complete medium in which to propagate B. burgdorferi organisms. When UV light-irradiated B. burgdorferi organisms were examined by dark-field microscopy, they appeared to have extremely reduced or no motility but retained their cellular integrity, preventing the release of large intracellular components into the medium.
TNF-
, IL-1
, IL-1
, and IL-8 activities in culture supernatants
were preceded by the up-regulation of their specific mRNAs in
tissues. Synovial explant tissues responded quickly to the challenge
with motile B. burgdorferi. Within 3 h of coincubation, tissues exposed to untreated spirochetes had maximal TNF-
, IL-1
, and IL-1
mRNA levels. However, maximal IL-8 mRNA levels appeared after 6 h of coincubation. Tissues exposed to UV light-irradiated spirochetes showed a delayed up-regulation of their cytokine mRNAs, with maximal mRNA levels found only after 6 h of exposure.
Considering that within any single experiment all explant tissues
received the same number of spirochetes, it appears likely that the
lack of motility and therefore a lack of invasiveness accounts for the
delayed cytokine up-regulation, which paralleled very well the
biological activity of all cytokines investigated.
The levels of biologically active TNF-like and IL-1-like factors did not reveal any statistically significant differences between untreated, UV light-irradiated, and sonicated borreliae at all time periods of the explant cultures. However, migration of PMNs toward culture supernatants was the highest for cultures containing synovial explant tissues exposed to untreated or sonicated spirochetes. UV light-irradiated B. burgdorferi, on the other hand, induced a significantly smaller chemotactic response. Since the same number of spirochetes was added to all cultures and no differences between TNF- and IL-1-like activity levels were observed, titration effects can be excluded. The only difference between the untreated and UV light-irradiated borreliae that we were aware of was the lack of motility, while the lack of cell integrity distinguished between untreated and sonicated borreliae. Surprisingly, sonicated borreliae induced the same chemotactic response as untreated spirochetes. The chemotactic factor(s) generated from the explant cultures is thought to be a chemokine such as IL-8, and presumably it can be induced by B. burgdorferi proteins as well as by intact, motile organisms. Why the addition of sonicated spirochetes to synovial explant tissues generated more chemotaxis than UV-light irradiated spirochetes is unknown, but it is possible that the sonication of spirochetes causes the release of additional chemotaxis-inducing factors.
In addition to contrasting the cytokine-inducing properties of untreated, irradiated, and sonicated borreliae, we compared the activities of high- and low-passage organisms. High- and low-passage B. burgdorferi induced cytokine responses of the same magnitude in our in vitro system. Kenefick et al. did not see passage-dependent effects on the production of IL-1 when B. burgdorferi was coincubated with peritoneal exudate cells or bovine peripheral blood monocytes (17, 18). It is interesting that both studies show that high-passage borreliae retain cytokine-inducing activities. It is possible, however, that those differences between high- and low-passage organisms will not be evident in in vitro systems which test activities over a 24-h period.
When the number of spirochetes added to the synovial explant cultures
was varied, an effect was noted with some cytokines but not with
others. A wide range of spirochete numbers induced similar TNF-like
activities in synovial tissue cells. One thousand bacteria per tissue
and a 104-fold higher bacterial load induced comparable TNF
responses. In contrast, only the maximal number of borreliae
(107) produced a substantial IL-1-like effect after 12 and
24 h of coincubation with synovial tissues. IL-8-like activities
were directly related to the dose of organisms added. An inoculum of 1,000 organisms induced no measurable IL-8-like activities. Considering the development of arthritis, these observations would favor an early
release of TNF, which seems to be easily and quickly triggered by small
numbers of spirochetes. In contrast, IL-8 appeared with a delay of at
least 3 h, possibly triggered indirectly by TNF-
and/or
directly by an interaction between synovial membrane cells and
spirochetes. Other groups have shown that either pathway can lead to
the up-regulation of IL-8. Eckmann et al. (9) have demonstrated that epithelial cells and fibroblasts respond with the
production and release of IL-8 upon penetration by bacteria. In
addition, in a recent publication by Burns et al. (6), it was shown that IL-8 is produced by umbilical endothelial cells in
response to B. burgdorferi but independently of the
secretion of IL-1 and TNF-
. Data published by Schröder et al.
(39) show clearly that TNF-
can induce the production and
release of IL-8 from fibrocytes. With regard to IL-1 production,
synovial explant tissues responded only to an inoculum of
107 or more spirochetes, suggesting that IL-1 is released
at times when synovial membranes might harbor large numbers of
spirochetes, such as during advanced, untreated infection.
We observed significant IL-1-like activity, but we were not able to
discriminate further whether canine IL-1
and/or IL-1
accounted
for these activities, due to the lack of specific neutralizing antibodies. Antibodies against IL-1 were directed against the human
cytokine, and it is possible that this preparation lacked sufficient
cross-reactivity to block the effect of canine IL-1
. However, we
could demonstrate that IL-1
and IL-1
mRNA levels were
up-regulated when synovial tissues were exposed to B. burgdorferi. TNF-
and IL-8 were confirmed to be present in
culture supernatants by the reduction of their biological activities by
neutralizing antibodies, by Western blotting (only IL-8), and by the
up-regulation of their specific mRNAs. Biological activities of TNF-
and IL-8 were abrogated incompletely when supernatants were treated
with antibodies to these cytokines. The failure of the neutralizing antibodies to totally abrogate cytokine activity can have several reasons. In the case of TNF-
, an insufficient interspecies
cross-reactivity may have prevented complete blocking. In the case of
IL-8, where we used species-specific hyperimmune serum, additional
factors, released from the explant tissues by the infection
(28), may have contributed to the residual cytokine
activities. Leukotriene B4 can induce the chemotaxis of
PMNs and was also found in synovial fluids from patients with Lyme
disease (26). In a complex system like an explant culture,
the release of multiple mediators must be expected, and it is likely
that in patients with Lyme arthritis, these factors may also contribute
to the initiation, maintenance, or termination of joint inflammation.
There is still uncertainty which factor(s) actually induces PMN
chemotaxis in vivo. Contradictory experimental results were obtained
for TNF-
and IL-1
: there are reports which indicate some
chemotactic activity for IL-1
(48, 49), while others deny
any chemotactic activity for IL-1
or TNF-
(29). In our
experiments, chemotactic activities were not related to TNF-like
activities or IL-1-like activities. While elevated TNF-like activities
were observed within 3 and 6 h after cocultivation of explant
tissues with borreliae, no significant chemotactic activities were
noted at that time. Similarly, 24-h culture supernatants of explant
tissues which received untreated or UV light-irradiated spirochetes
expressed levels of IL-1-like activities that were not significantly
different, but their chemotaxis indices differed significantly, by more
than two SE units. Similarly, we observed chemotactic activities in
cultures which had received 105 spirochetes, but identical
samples showed no IL-1-like activity. Thus, chemotactic activity in
explant culture supernatants is ascribed to IL-8; whether IL-8
production was triggered by the spirochete alone or by an
earlier-up-regulated cytokine will require further study.
Our hypothesis of the pathogenesis of acute Lyme arthritis emphasizes the involvement of local inflammatory factors and PMNs. However, studies by Schell and colleagues have concentrated on the involvement of borreliacidal antibodies and T lymphocytes (CD4+ and CD8+) in the pathogenesis of Lyme disease (21-23). In our opinion, T-lymphocyte-mediated Lyme arthritis differs from the initial arthritis that we see in tick-induced experimental canine infection. In our dogs, an accumulation of lymphocytes and plasma cells in the synovial membrane occurs after several months of infection (1). Only very small amounts of borreliacidal antibodies are present at this time, and the nonsuppurative arthritis is subclinical (44).
Diverse and sometimes contradictory information exists regarding the development of Lyme arthritis; a detailed characterization of the pathogenesis will be essential for successful treatment and the development of safe vaccines. Data describing the regulation and kinetics of cytokines and specific immune factors are difficult to obtain in vivo. Our explant tissue culture system allows the study of complex mechanisms without scarifying the structure of the synovial tissue. Feedback mechanisms can develop and can be studied in detail, which makes this system a valuable tool for the further study of Lyme arthritis.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by the National Institutes of Health (contract N01-AI-45254) and by the Gottlieb Daimler- und Karl Benz-Stiftung, Ladenburg, Germany.
We thank Mary Beth Matychak for her excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853. Phone: (607) 256-5637. Fax: (607) 256-5608. E-mail: rks4{at}cornell.edu.
Editor: R. E. McCallum
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Appel, M. J. G., S. Allen, R. H. Jacobson, T.-L. Lauderdale, Y.-F. Chang, S. J. Shin, J. W. Thomford, R. J. Todhunter, and B. A. Summers. 1993. Experimental Lyme disease in dogs produces arthritis and persistent infection. J. Infect. Dis. 167:651-664[Medline]. |
| 2. |
Baggiolini, M.,
B. Dewald, and B. Moser.
1994.
Interleukin-8 and related chemotactic cytokines CXC and CC chemokines.
Adv. Immunol.
55:97-179[Medline].
|
| 3. |
Barbour, A. G.
1988.
Laboratory aspects of Lyme borreliosis.
Clin. Microbiol. Rev.
1:399-414 |
| 4. | Barthold, S. W., M. S. DeSouza, J. L. Janotka, A. L. Smith, and D. H. Persing. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143:959-971[Abstract]. |
| 5. | Beck, G., J. L. Benach, and G. S. Habicht. 1989. Isolation of interleukin 1 from joint fluids of patients with Lyme disease. J. Rheumatol. 16:800-806[Medline]. |
| 6. | Burns, M. J., T. Sellati, J., E. I. Teng, and M. B. Furie. 1997. Production of interleukin-8 (IL-8) by cultured endothelial cells in response to Borrelia burgdorferi occurs independently of secretion IL-1 and tumor necrosis factor alpha and is required for subsequent transendothelial migration of neutrophils. Infect. Immun. 65:1217-1222[Abstract]. |
| 7. | Chang, Y.-F., R. K. Straubinger, R. H. Jacobson, J. B. Kim, T. J. Kim, D. Kim, S. J. Shin, and M. J. G. Appel. 1996. Dissemination of Borrelia burgdorferi after experimental infection in dogs. J. Spirochetal Tick-Borne Dis. 3:80-86. |
| 8. |
Defosse, D. L., and R. C. Johnson.
1992.
In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi.
Infect. Immun.
60:1109-1113 |
| 9. |
Eckmann, L.,
M. F. Kagnoff, and J. Fierer.
1993.
Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry.
Infect. Immun.
61:4569-4574 |
| 10. | Georgilis, K., R. Noring, A. C. Steere, and M. S. Klempner. 1991. Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. Arthritis Rheum. 34:770-775[Medline]. |
| 11. | Gilmore, W. H., S. D. Carter, M. Bennett, A. Barnes, and D. F. Kelly. 1996. Expression of canine TNF, IL-1 and IL-6 mRNAs in peripheral blood monocytes and cell lines. GenBank accession no. Z70047. |
| 12. | Hulinska, D., J. Jirous, M. Valesova, and J. Herzogova. 1989. Ultrastructure of Borrelia burgdorferi in tissues of patients with Lyme disease. J. Basic Microbiol. 29:73-83[Medline]. |
| 13. | Hurtenbach, U., C. Museteanu, J. Gasser, U. E. Schaible, and M. M. Simon. 1995. Studies on early events of Borrelia burgdorferi-induced cytokine production in immunodeficient SCID mice by using a tissue chamber model for acute inflammation. Int. J. Exp. Pathol. 76:111-123[Medline]. |
| 14. | Ishikawa, J., S. Suzuki, K. Hotta, Y. Hirota, S. Mizuno, and K. Suzuki. 1993. Cloning of a canine gene homologous to the human interleukin-8-encoding gene. Gene 131:305-306[Medline]. |
| 15. | Judd, A. M., and R. M. MacLeod. 1992. The regulation of interleukin 6 and tumor necrosis factor release from primary cultures of ovarian cells. Prog. Neuroendocrinoimmunol. 5:245-255. |
| 16. | Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155:2020-2028[Abstract]. |
| 17. |
Kenefick, K. B.,
J. A. Lederer,
R. F. Schell, and C. J. Czuprynski.
1992.
Borrelia burgdorferi stimulates release of interleukin-1 activity from bovine peripheral blood monocytes.
Infect. Immun.
60:3630-3634 |
| 18. | Kenefick, K. B., L. C. L. Lim, J. D. Alder, J. L. Schmitz, C. J. Czuprynski, and R. F. Schell. 1993. Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J. Infect. Dis. 167:1086-1092[Medline]. |
| 19. | Knigge, H., M. M. Simon, S. C. Meuer, M. D. Kramer, and R. Wallich. 1996. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes. Eur. J. Immunol. 26:2299-2303[Medline]. |
| 20. |
Leong, S. R.,
G. M. Flaggs,
M. Lawman, and P. W. Gray.
1988.
The nucleotide sequence for the cDNA of bovine interleukin-1 .
Nucleic Acids Res.
16:9053 |
| 21. |
Lim, L. C. L.,
D. M. England,
B. K. DuChateau,
N. J. Glowacki,
J. R. Creson,
S. D. Lovrich,
S. M. Callister,
D. A. Jobe, and R. F. Schell.
1994.
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.
Infect. Immun.
62:2825-2833 |
| 22. | Lim, L. C. L., D. M. England, B. K. DuChateau, N. J. Glowacki, and R. F. Schell. 1995. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63:1400-1408[Abstract]. |
| 23. | Lim, L. C. L., D. M. England, N. J. Glowacki, B. K. DuChateau, and R. F. Schell. 1995. Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters. Infect. Immun. 63:4818-4825[Abstract]. |
| 24. |
Ma, Y., and J. J. Weis.
1993.
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
Infect. Immun.
61:3843-3853 |
| 25. | May, C., S. D. Carter, A. Barnes, C. McLean, D. Bennett, A. Coutts, and C. K. Grant. 1994. Borrelia burgdorferi infection in cats in the UK. J. Small Anim. Pract. 35:517-520. |
| 26. | Mayatepek, E., D. Hassler, and M. Maiwald. 1993. Enhanced levels of leukotriene B4 in synovial fluid in Lyme disease. Mediators Inflamm. 2:225-228. |
| 27. |
Miller, L. C.,
E. A. Lynch,
S. Isa,
J. W. Logan,
C. A. Dinarello, and A. C. Steere.
1993.
Balance of synovial fluid IL-1 and IL-1 receptor antagonist and recovery from Lyme arthritis.
Lancet
341:146-148[Medline].
|
| 28. | Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17-46[Medline]. |
| 29. | Mulder, K., and I. G. Colditz. 1993. Migratory responses of ovine neutrophils to inflammatory mediators in vitro and in vivo. J. Leukocyte Biol. 53:273-278[Abstract]. |
| 30. |
Nishida, T.,
N. Nishino,
M. Takano,
K. Kawai,
K. Bando,
Y. Masui,
S. Nakai, and Y. Hirai.
1987.
cDNA cloning of IL-1 and IL-1 from mRNA of U937 cell line.
Biochem. Biophys. Res. Commun.
143:345-352[Medline].
|
| 31. |
Nishida, T.,
N. Nishino,
M. Takano,
Y. Sekiguchi,
K. Kawai,
K. U. Mizuno,
S. Nakai,
Y. Masui, and Y. Hirai.
1989.
Molecular cloning and expression of rat interleukin-1 cDNA.
J. Biochem.
105:351-357 |
| 32. |
Norgard, M. V.,
L. L. Arndt,
D. R. Akins,
L. L. Curetty,
D. A. Harrich, and J. D. Radolf.
1996.
Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF- B.
Infect. Immun.
64:3845-3852[Abstract].
|
| 33. | Parker, J. L., and K. K. White. 1992. Lyme borreliosis in cattle and horses: a review of the literature. Cornell Vet. 82:253-274[Medline]. |
| 34. | Porat, R., D. D. Poutsiaka, L. C. Miller, E. V. Granowitz, and C. A. Dinarello. 1993. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J. 6:2482-2486[Abstract]. |
| 35. | Preac-Mursic, V., E. Patsouris, B. Wilske, S. Reinhardt, B. Gross, and P. Mehraein. 1990. Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human disease. Infection 18:332-341[Medline]. |
| 36. | Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. J. Immunol. 147:1968-1974[Abstract]. |
| 37. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. . Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 38. | Schefler, W. C. 1984. . Statistics for health professionals. Addison-Wesley Publication Company, Inc., Reading, Mass. |
| 39. |
Schröder, J. M.,
M. Sticherling,
H. H. Henneicke,
W. C. Preissiner, and E. Christophers.
1990.
IL-1 or tumor necrosis factor- stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts.
J. Immunol.
144:2223-2232[Abstract].
|
| 40. | Schulze, J., S. Breitner-Ruddock, H. Von Briesen, and V. Brade. 1996. High and low level cytokine induction in human peripheral blood mononuclear cells by different Borrelia burgdorferi strains. Med. Microbiol. Immunol. 185:31-37[Medline]. |
| 41. | Steere, A. C. 1989. Lyme disease. N. Engl. J. Med. 321:586-596[Abstract]. |
| 42. | Steere, A. C., P. H. Duray, and E. C. Butcher. 1988. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 31:487-495[Medline]. |
| 43. | Stevens, M. G., and S. C. Olsen. 1993. Comparative analysis of using MTT and XTT in colorimetric assay for quantitating bovine neutrophil bactericidal activity. J. Immunol. Methods 157:225-231[Medline]. |
| 44. | Straubinger, R. K., Y.-F. Chang, R. H. Jacobson, and M. J. G. Appel. 1995. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J. Clin. Microbiol. 33:2745-2751[Abstract]. |
| 45. | Straubinger, R. K., A. F. Straubinger, L. Härter, R. H. Jacobson, Y.-F. Chang, B. A. Summers, H. N. Erb, and M. J. G. Appel. 1997. Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect. Immun. 65:1273-1285[Abstract]. |
| 46. |
Tai, K.-F.,
Y. Ma, and J. J. Weis.
1994.
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.
Infect. Immun.
62:520-528 |
| 47. | Tanaka, T., F. Shibasaki, M. Ishikawa, N. Hirano, R. Sakai, J. Nishida, T. Takenawa, and H. Hirai. 1992. Molecular cloning of bovine actin-like protein actin 2. Biochem. Biophys. Res. Commun. 187:1022-1028[Medline]. |
| 48. |
Thomsen, M. K.
1990.
Is interleukin-1 a direct activator of neutrophil migration and phagocytosis in the dog?
Agent Actions
29:35-36[Medline].
|
| 49. |
Thomsen, M. K., and H. K. Thomsen.
1990.
Effects of interleukin-1 on migration of canine neutrophils in vitro and in vivo.
Vet. Immunol. Immunopathol.
26:385-393[Medline].
|
| 50. | Van Dam, A. P., H. Kuiper, K. Vos, A. Widjojokusumo, B. M. De Jongh, L. Spanjaard, A. C. P. Ramselaar, M. D. Kramer, and J. Dankert. 1993. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17:708-717[Medline]. |
| 51. | Villinger, F., S. S. Brar, A. Mayne, N. Chikkala, and A. A. Ansari. 1995. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155:3946-3954[Abstract]. |
| 52. | Yamashita, K., T. Fujinaga, M. Hagio, T. Miyamoto, Y. Izumisawa, and T. Kotani. 1994. Bioassay for interleukin-1, interleukin-6, and tumor necrosis factor-like activities in canine sera. J. Vet. Med. Sci. 56:103-107[Medline]. |
| 53. |
Yssel, H.,
T. Nakamoto,
P. Schneider,
V. Freitas,
C. Collins,
D. Webb,
N. Mensi,
C. Soderberg, and G. Peltz.
1990.
Analysis of T lymphocytes cloned from the synovial fluid and blood of a patient with Lyme arthritis.
Int. Immunol.
2:1081-1090 |
| 54. | Yuan, H. T., F. J. Kelly, and C. D. Bingle. 1996. Cloning and characterization of guinea pig TNF- ,
IL-1 , and GM-CSF cDNA sequences. GenBank accession no. U46778.
|
| 55. | Zucker, K., P. Lu, L. Fuller, D. Asthana, V. Esquenazi, and J. Miller. 1994. Cloning and expression of the cDNA for canine TNF-alpha in E. coli. Lymphokine Cytokine Res. 13:191-196[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»